Literature DB >> 8687448

Mammalian mature osteoclasts as estrogen target cells.

H Mano1, T Yuasa, T Kameda, K Miyazawa, Y Nakamaru, M Shiokawa, Y Mori, T Yamada, K Miyata, H Shindo, H Azuma, Y Hakeda, M Kumegawa.   

Abstract

The decrease in estrogen levels that follows the onset of menopause causes rapid bone loss, resulting in osteoporosis. However, the mechanism by which this occurs remains unclear, especially concerning the regulation of osteoclasts, i.e. the bone-resorbing cells. Using a pit assay involving isolated mature osteoclasts from rabbit long bones, we found that estrogen inhibited the bone-resorbing activity in a dose- and time-dependent manner. Furthermore, we clarified by Northern analysis that estrogen down-regulated the mRNA levels of cathepsin K/OC-2 and that putative estrogen receptor (ER) mRNA was expressed in these osteoclasts. Moreover, other sizes of mRNAs that hybridized with ER cDNA probe were found in these cells. Our results suggest that osteoclasts may be indeed target cells for estrogen and that estrogen might regulate a part of bone metabolism through osteoclasts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8687448     DOI: 10.1006/bbrc.1996.0947

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

Review 1.  Skeletal effects of estrogens.

Authors:  G Fiorelli; M L Brandi
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

Review 2.  Estrogen and bones after menopause: a reappraisal of data and future perspectives.

Authors:  Panagiotis Anagnostis; Julia K Bosdou; Konstantina Vaitsi; Dimitrios G Goulis; Irene Lambrinoudaki
Journal:  Hormones (Athens)       Date:  2020-06-09       Impact factor: 2.885

3.  LCC15-MB: a vimentin-positive human breast cancer cell line from a femoral bone metastasis.

Authors:  E W Thompson; V Sung; M Lavigne; K Baumann; N Azumi; A D Aaron; R Clarke
Journal:  Clin Exp Metastasis       Date:  1999-05       Impact factor: 5.150

Review 4.  Direct transcriptional targets of sex steroid hormones in bone.

Authors:  Susan A Krum
Journal:  J Cell Biochem       Date:  2011-02       Impact factor: 4.429

5.  Estrogen's bone-protective effects may involve differential IL-1 receptor regulation in human osteoclast-like cells.

Authors:  T Sunyer; J Lewis; P Collin-Osdoby; P Osdoby
Journal:  J Clin Invest       Date:  1999-05-15       Impact factor: 14.808

Review 6.  Estrogens and Androgens in Skeletal Physiology and Pathophysiology.

Authors:  Maria Almeida; Michaël R Laurent; Vanessa Dubois; Frank Claessens; Charles A O'Brien; Roger Bouillon; Dirk Vanderschueren; Stavros C Manolagas
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

7.  The response to oestrogen deprivation of the cartilage collagen degradation marker, CTX-II, is unique compared with other markers of collagen turnover.

Authors:  Anne-Christine Bay-Jensen; Nadine C B Tabassi; Lene V Sondergaard; Thomas L Andersen; Frederik Dagnaes-Hansen; Patrick Garnero; Moustapha Kassem; Jean-Marie Delaissé
Journal:  Arthritis Res Ther       Date:  2009       Impact factor: 5.156

Review 8.  Cathepsin K inhibitors for osteoporosis and potential off-target effects.

Authors:  Dieter Brömme; Fabien Lecaille
Journal:  Expert Opin Investig Drugs       Date:  2009-05       Impact factor: 6.206

9.  Aging and menopause reprogram osteoclast precursors for aggressive bone resorption.

Authors:  Anaïs Marie Julie Møller; Jean-Marie Delaissé; Jacob Bastholm Olesen; Jonna Skov Madsen; Luisa Matos Canto; Troels Bechmann; Silvia Regina Rogatto; Kent Søe
Journal:  Bone Res       Date:  2020-07-01       Impact factor: 13.567

10.  Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro.

Authors:  H Michael; P L Härkönen; L Kangas; H K Väänänen; T A Hentunen
Journal:  Br J Pharmacol       Date:  2007-04-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.